R&D | October 28, 2025
MilliporeSigma partners with Promega to advance 3-D cell drug discovery technologies
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
Bajaj Healthcare has reported total income of Rs. 149.56 crore during the period ended September 30, 2025
RPG Life Sciences has reported total income of Rs. 186.22 crore during the period ended September 30, 2025
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Vamikibart is the first targeted, non-steroid treatment designed to address the underlying inflammation driving UME
Subscribe To Our Newsletter & Stay Updated
